Authors:
GILBERT CJ
PETROS WP
VREDENBURGH J
HUSSEIN A
ROSS M
RUBIN P
FEHDRAU R
CAVANAUGH C
BERRY D
MCKINSTRY C
PETERS WP
Citation: Cj. Gilbert et al., PHARMACOKINETIC INTERACTION BETWEEN ONDANSETRON AND CYCLOPHOSPHAMIDE DURING HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 497-503
Authors:
RICHARDSON PG
ELIAS AD
KRISHNAN A
WHEELER C
NATH R
HOPPENSTEADT D
KINCHLA NM
NEUBERG D
WALLER EK
ANTIN JH
SOIFFER R
VREDENBURGH J
LILL M
WOOLFREY AE
BEARMAN SI
IACOBELLI M
FAREED J
GUINAN EC
Citation: Pg. Richardson et al., TREATMENT OF SEVERE VENOOCCLUSIVE DISEASE WITH DEFIBROTIDE - COMPASSIONATE USE RESULTS IN RESPONSE WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION, Blood, 92(3), 1998, pp. 737-744
Authors:
BOLWELL B
VREDENBURGH J
OVERMOYER B
GILBERT C
CHAP L
MENCHACA D
SCARLATA D
GLASPY J
Citation: B. Bolwell et al., SAFETY AND BIOLOGIC EFFECT OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) IN BREAST CANTER PATIENTS FOLLOWING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPC), Blood, 90(10), 1997, pp. 756-756
Authors:
VREDENBURGH J
GLASPY J
BOLWELL B
DEMETRI GD
KIN B
JELACAMAXWELL K
SHPALL EJ
Citation: J. Vredenburgh et al., THE INCIDENCE OF THROMBOTIC AND EMBOLIC EVENTS IN CONTROLLED CLINICAL-TRIALS OF BREAST-CANCER (CA) PATIENTS (PTS) UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC) WITH THE STAMP-I REGIMEN AND AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION, Blood, 90(10), 1997, pp. 972-972
Authors:
RICHARDSON PG
ELIAS AD
KRISHNAN A
WHEELER C
NATH R
HOPPENSTEADT D
WALLER EK
ANTIN JH
SOIFFER RJ
VREDENBURGH J
BEARMAN SI
IACOBELLI M
FAREED J
GUINAN EC
Citation: Pg. Richardson et al., TREATMENT OF SEVER VENOOCCLUSIVE DISEASE (VOD) WITH DEFIBROTIDE (DF) - COMPASSIONATE USE RESULTS IN EFFICACY WITHOUT SIGNIFICANT TOXICITY IN A HIGH-RISK POPULATION, Blood, 90(10), 1997, pp. 1107-1107
Authors:
GLASPY J
VREDENBURGH J
DEMETRI GD
CHAP L
GILBERT C
OVERMOYER B
WARREN DL
BERG R
SCARLATA D
MENCHACA D
BOLWELL B
Citation: J. Glaspy et al., EFFECTS OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) BEFORE HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT, Blood, 90(10), 1997, pp. 2582-2582
Authors:
HUSSEIN A
VREDENBURGH J
ELKORDY M
RUBIN P
FISHER D
CANALES R
PETROS W
GILBERT C
PERET N
DYKSTRA K
LOEWY J
KAYE JA
PETERS WP
Citation: A. Hussein et al., RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) IN PATIENTS WITH BREAST-CANCERFOLLOWING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL (AHPC) SUPPORT, Experimental hematology, 24(9), 1996, pp. 634-634
Authors:
INGRAM SS
SAMULSKI T
DODGE R
PROSNITZ LR
PETERS P
VREDENBURGH J
Citation: Ss. Ingram et al., THE EFFECTS OF HYPERTHERMIA IN BONE-MARROW PURGING OF BREAST-CANCER, International journal of hyperthermia, 12(1), 1996, pp. 21-29
Authors:
VREDENBURGH J
RUBIN P
ELKORDY M
CREWS J
PETERS WP
LEGRAND S
DEFUSCO P
Citation: J. Vredenburgh et al., SECONDARY MYELODYSPLASIA (MDS) ACUTE LEUKEMIA (AL) AFTER HIGH-DOSE CHEMOTHERAPY FOR METASTIC BREAST-CANCER/, Blood, 88(10), 1996, pp. 1034-1034
Authors:
HUSSEIN A
FISHER D
VREDENBURGH J
RUBIN P
ELKORKY M
PETER W
PERET N
DYKSTRA K
KAYE JA
Citation: A. Hussein et al., PHASE-2 TRIAL OF NEUMEGA(R) RHIL-11 IN PATIENTS WITH BREAST-CANCER AFTER HIGH-DOSE CHEMOTHERAPY WITH BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL SUPPORT, Blood, 88(10), 1996, pp. 1189-1189
Authors:
HUSSEIN AM
ROSS M
VREDENBURGH J
MEISENBERG B
HARS V
GILBERT C
PETROS WP
CONIGLIO D
KURTZBERG J
RUBIN P
PETERS WP
Citation: Am. Hussein et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PRODUCED IN CHINESE-HAMSTER OVARY CELLS (REGRAMOSTIM), ESCHERICHIA-COLI (MOLGRAMOSTIM) AND YEAST (SARGRAMOSTIM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY, European journal of haematology, 54(5), 1995, pp. 281-287
Authors:
GILBERT C
MEISENBERG B
VREDENBURGH J
ROSS M
HUSSEIN A
PERFECT J
PETERS WP
Citation: C. Gilbert et al., SEQUENTIAL PROPHYLACTIC ORAL AND EMPIRIC ONCE-DAILY PARENTERAL ANTIBIOTICS FOR NEUTROPENIA AND FEVER AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT, Journal of clinical oncology, 12(5), 1994, pp. 1005-1011
Authors:
MUDAD R
VREDENBURGH J
PAULSON EK
ROSS M
MEISENBERG B
HUSSEIN A
PETERS WP
Citation: R. Mudad et al., A RADIOLOGIC SYNDROME AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, WITH CLINICAL AND PATHOLOGICAL FEATURES OF SYSTEMIC CANDIDIASIS, Cancer, 74(4), 1994, pp. 1360-1366
Authors:
VREDENBURGH J
WATERSPICK B
DRAGO S
AFFRONTI ML
KURTZBERG J
ROSS M
HUSSEIN A
RUBIN P
ELKORDY M
MEISENBERG B
PETERS WP
Citation: J. Vredenburgh et al., G-CSF-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) COLLECTED IN THE STEADY-STATE ARE SUPERIOR TO G-CSF-PRIMED PBPCS COLLECTED ON THE REBOUND FROM CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000107-10000107
Authors:
PETERS WP
ROSS M
VREDENBURGH J
HUSSEIN A
MEISENBERG B
GILBERT C
PETROS WP
KURTZBERG J
Citation: Wp. Peters et al., ROLE OF CYTOKINES IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Hematology/oncology clinics of North America, 7(3), 1993, pp. 737-747
Authors:
HUSSEIN A
ROSS M
VREDENBURGH J
MEISENBERG B
GILBERT C
PETROS W
CONIGLIO D
KURTZBERG J
PETERS WP
Citation: A. Hussein et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) EXPRESSED IN CHINESE-HAMSTER OVARY CELLS (CHO-GM), ESCHERICHIA-COLI (E-COLI-GM) OR YEAST (YEAST-GM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY, Blood, 82(10), 1993, pp. 10000293-10000293